Hostname: page-component-84b7d79bbc-4hvwz Total loading time: 0 Render date: 2024-07-30T09:10:33.757Z Has data issue: false hasContentIssue false

Interim Relief in Case of Inclusion of a Substance on the REACH Candidate List

Published online by Cambridge University Press:  20 January 2017

Nicolas Herbatschek
Affiliation:
Hunton & Williams, Brussels, Belgium

Abstract

The manufacturer of a substance that is used safely and, in more than 99.9% of cases, used as an intermediate (and thereforeis exempted from the authorisation procedure) is deemed to have no legal grounds for claiming the suspension of the inclusion of that substance in the Candidate List for lack of urgency. Its mere inclusion should not automatically result in any significant damages to the manufacturer, neither should the Candidate List serve as a regulatory blacklist (official headnote).

Type
Case Notes
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

** Editorial Hint: Article 2(8) and 59 of Regulation 1907/2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), last amended by Regulation 552/2009, OJ L – 396, of 30.12.1996, pp. 1–849.

1 From the decision, it seems that acrylamide is used as isolated intermediate.

4 “Suspend the operation of the contested decision pursuant to Article 105(2) of the Rules of Procedure of the Court, pending the ruling on the application for interim measures; in any event, suspend the operation of the contested decision with effect from the date on which it was adopted; grant any other interim measures as appropriate.”

5 There are also exemptions available from the authorisation requirement.